A proposal to transform phase 1 oncology trials at company xyz Laiya Consulting, Inc. September 28, 2019 Purpose: To promote the use of a novel phase 1 trial design suite that tailors to the modern needs of phase 1 clinical trials in oncology. Introduction: Based on a set of innovative statistical designs and approaches, Laiya[…]
Position: Junior / Senior Statistician (with focus on methodology development and application) Education: PhD in statistics, biostatistics, mathematics, or equivalent, open for fresh PhD Responsibilities: Develop novel statistical methods (especially in the Bayesian adaptive designs) for real-world clinical trials. Study existing statistical literature on clinical trial methodology and practical challenges in drug clinical trials. Attend[…]
Laiya founder Yuan Ji, Professor of Biostatistics at The University of Chicago, presented a poster entitled “The i3+3 Design for Phase I Clinical Trials” at 2019 ASCO Annual Meeting in Chicago, USA. The i3+3 design is the first rule-based dose-finding design with a performance in par with model-based designs like mTPI and mTPI-2. The paper[…]